HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma

Published:2023-05-10 Issue:1 Volume:14 Page:439-443
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Desai Omkar¹²,Wang Rui¹²³

Affiliation:

1. Department of Surgery, Case Western Reserve University, Cleveland, OH 44106, USA

2. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA

3. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference41 articles.

1. Cancer statistics, 2023;Jemal;CA Cancer J Clin,2023

2. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer stat facts: colorectal cancer. Accessed February, 2023. https://seer.cancer.gov/statfacts/html/colorect.html.

3. Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up;Oliveira;Ann Oncol,2009

4. Cancer statistics, 2022;Jemal;CA Cancer J Clin,2022

5. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer stat facts: Pancreatic Cancer. Accessed February, 2023. https://seer.cancer.gov/statfacts/html/pancreas.html.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and antitumor activity of 3,4,5-Trisubstituted Isoxazoles;European Journal of Medicinal Chemistry Reports;2024-12

2. Industry news update, May 2023;Therapeutic Delivery;2023-05